Cargando…

Impact of an Expanded Hospital Recognition Program for Heart Failure Quality of Care

BACKGROUND: In 2009, the Get With The Guidelines–Heart Failure program enhanced the standard recognition of hospitals by offering additional recognition if hospitals performed well on certain quality measures. We sought to determine whether initiation of this enhanced recognition opportunity led to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heidenreich, Paul A., Zhao, Xin, Hernandez, Adrian F., Yancy, Clyde W., Schwamm, Lee H., Albert, Nancy M., Fonarow, Gregg C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323821/ https://www.ncbi.nlm.nih.gov/pubmed/25208954 http://dx.doi.org/10.1161/JAHA.114.000950

Ejemplares similares

Impact of an Expanded Hospital Recognition Program for Stroke Quality of Care
por: Heidenreich, Paul A., et al.
Publicado: (2017)

Association of Electronic Health Record Use With Quality of Care and Outcomes in Heart Failure: An Analysis of Get With The Guidelines—Heart Failure
por: Selvaraj, Senthil, et al.
Publicado: (2018)

Heart Rate at Hospital Discharge in Patients With Heart Failure Is Associated With Mortality and Rehospitalization
por: Laskey, Warren K., et al.
Publicado: (2015)

Racial Differences in the Prevalence and Outcomes of Atrial Fibrillation Among Patients Hospitalized With Heart Failure
por: Thomas, Kevin L., et al.
Publicado: (2013)

Regional Variations in Heart Failure Quality and Outcomes: Get With The Guidelines–Heart Failure Registry
por: Cunningham, Luke C., et al.
Publicado: (2021)

Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease
por: Cooper, Lauren B., et al.
Publicado: (2017)

Initiation, Continuation, or Withdrawal of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction
por: Gilstrap, Lauren G., et al.
Publicado: (2017)

Short‐ and Long‐term Rehospitalization and Mortality for Heart Failure in 4 Racial/Ethnic Populations
por: Vivo, Rey P., et al.
Publicado: (2014)

Timing of Postdischarge Follow‐Up and Medication Adherence Among Patients With Heart Failure
por: Chang, Leslie L., et al.
Publicado: (2018)

Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes
por: Goldstein, Sarah A., et al.
Publicado: (2018)

Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention
por: Khazanie, Prateeti, et al.
Publicado: (2015)

Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction
por: Greene, Stephen J., et al.
Publicado: (2021)

Use of Hydralazine‐Isosorbide Dinitrate Combination in African American and Other Race/Ethnic Group Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction
por: Golwala, Harsh B., et al.
Publicado: (2013)

Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines—Heart Failure
por: Kelly, Jacob P., et al.
Publicado: (2019)

Clinical Profile, Health Care Costs, and Outcomes of Patients Hospitalized for Heart Failure With Severely Reduced Ejection Fraction
por: Harrington, Josephine, et al.
Publicado: (2023)

Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HF
por: Fonarow, Gregg C., et al.
Publicado: (2012)

The Critical Need for Process Improvement in Heart Failure
por: Yancy, Clyde W., et al.
Publicado: (2020)

Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure
por: Echols, Melvin R, et al.
Publicado: (2006)

Relationship Between Hospital Characteristics and Early Adoption of Angiotensin‐Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart Failure
por: Luo, Nancy, et al.
Publicado: (2019)

Association of the New Peer Group–Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program
por: McCarthy, Cian P., et al.
Publicado: (2019)

Patterns of Care Quality and Prognosis Among Hospitalized Ischemic Stroke Patients With Chronic Kidney Disease
por: Ovbiagele, Bruce, et al.
Publicado: (2014)

In‐Hospital Worsening Heart Failure and Associations With Mortality, Readmission, and Healthcare Utilization
por: DeVore, Adam D., et al.
Publicado: (2014)

Comparison of Performance Achievement Award Recognition With Primary Stroke Center Certification for Acute Ischemic Stroke Care
por: Fonarow, Gregg C., et al.
Publicado: (2013)

Eligibility of sodium–glucose co‐transporter‐2 inhibitors among patients with diabetes mellitus admitted for heart failure
por: Sharma, Abhinav, et al.
Publicado: (2019)

Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America
por: Bhatt, Ankeet S., et al.
Publicado: (2022)

COVID-19, Heart Failure Hospitalizations, and Outcomes: A Nationwide Analysis
por: Isath, Ameesh, et al.
Publicado: (2023)

The American Heart Association’s Get With the Guidelines (GWTG)-Stroke development and impact on stroke care
por: Ormseth, Cora H, et al.
Publicado: (2017)

Comparison of Machine Learning Algorithms for Predicting Hospital Readmissions and Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction: Modeling Study
por: Ru, Boshu, et al.
Publicado: (2023)

Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure
por: Talha, Khawaja M., et al.
Publicado: (2022)

A paradoxical relationship between hemoglobin A1C and in-hospital mortality in intracerebral hemorrhage patients
por: Dandapat, Sudeepta, et al.
Publicado: (2019)

Heart Failure With Preserved Ejection Fraction and Obesity: Syndrome of cGMP-PKG Deficiency in Post-Menopausal Women
por: Sinha, Arjun, et al.
Publicado: (2020)

Comparative Effectiveness of Primary Prevention Implantable Cardioverter‐Defibrillators in Older Heart Failure Patients With Diabetes Mellitus
por: Sharma, Abhinav, et al.
Publicado: (2020)

Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection Fraction
por: Brownell, Nicholas K., et al.
Publicado: (2022)

International Comparison of Patient Characteristics and Quality of Care for Ischemic Stroke: Analysis of the China National Stroke Registry and the American Heart Association Get With The Guidelines––Stroke Program
por: Wangqin, Runqi, et al.
Publicado: (2018)

Paradoxical Association of Smoking With In‐Hospital Mortality Among Patients Admitted With Acute Ischemic Stroke
por: Ali, Syed F., et al.
Publicado: (2013)

Systematic examination of a heart failure risk prediction tool: The pooled cohort equations to prevent heart failure
por: Bavishi, Aakash, et al.
Publicado: (2020)

Hypokalaemia and outcomes in older patients hospitalized for heart failure
por: Valentova, Miroslava, et al.
Publicado: (2020)

Absence of July Phenomenon in Acute Ischemic Stroke Care Quality and Outcomes
por: Gonzalez‐Castellon, Marco, et al.
Publicado: (2018)

Discharge home health services referral and 30-day all-cause readmission in older adults with heart failure
por: Arundel, Cherinne, et al.
Publicado: (2018)

Reply: Alternative Models of Cardiac Rehabilitation Delivery Urgently Needed to Improve Access for Heart Failure Patients
por: Keshvani, Neil, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pmq465rnbou4ecsq516j8356qn